Home.forex news reportApple’s stock can climb 35% this year — if these four scenarios... .forex news report Apple’s stock can climb 35% this year — if these four scenarios play out By Forex News Report - January 12, 2026 4 0 FacebookTwitterPinterestWhatsApp None Source link FacebookTwitterPinterestWhatsApp Previous article“On Paper, This One’s a Standout”Next article“I Think It Is a Buy” Forex News Reporthttps://www.forexnewsreport.com LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment. LATEST POSTS .forex news report FX Watch: USD/JPY and AUD/USD’s Setups if U.S. CPI Encourages Aggressive Fed Rate Cuts Will U.S. dollar bears make a comeback as Uncle Sam rolls out its latest inflation updates? Our Event Guide for the U.S. CPI report points... January 12, 2026 .forex news report Truist Raises PT on Amneal Pharmaceuticals (AMRX) to $15 From $14 Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) is one of the best performing pharma stocks in 2025. On January 7, Truist raised the price... January 12, 2026 .forex news report Amarin Corporation (AMRN) Announces Select Unaudited Financial Highlights Amarin Corporation plc (NASDAQ:AMRN) is one of the best performing pharma stocks in 2025. Amarin Corporation plc (NASDAQ:AMRN) announced select unaudited... January 12, 2026 .forex news report Jefferies Reaffirms a Buy Rating on GSK plc (GSK) – Here’s Why GSK plc (NYSE:GSK) is one of the best performing pharma stocks in 2025. Jefferies reaffirmed a Buy rating on GSK plc... January 12, 2026 Load more Follow us0FansLike0FollowersFollow0SubscribersSubscribe Most Popular FX Watch: USD/JPY and AUD/USD’s Setups if U.S. CPI Encourages Aggressive Fed Rate Cuts Truist Raises PT on Amneal Pharmaceuticals (AMRX) to $15 From $14 Amarin Corporation (AMRN) Announces Select Unaudited Financial Highlights Jefferies Reaffirms a Buy Rating on GSK plc (GSK) – Here’s Why Eli Lilly and Company (LLY) to Acquire Ventyx Biosciences
